3rd Quarter - Report

TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC

Firm
Client
Income
—
Expenses
$254,295
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Consumer Issues/Safety/Products CSP

H.R. 1346/S. 540 The Medical Device Safety Act

LobbyistCovered position, as disclosed
ANDREA WILKINSON Sen. Breaux, House MMF Comm., Cong. McCrery

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1346 (111th), S. 540 (111th)

Clean Air and Water (quality) CAW

H.R. 1262 Water Quality Investment Act

LobbyistCovered position, as disclosed
ANDREA WILKINSON Sen. Breaux, House MMF Comm., Cong. McCrery

Contacted: SENATE; Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1262 (111th)

Trade (domestic/foreign) TRD

S. 369 Preserve Access to Affordable Generics Act; HR 573 FDCA to prohibit the marketing of authorized generic drugs Act; S. 501 Fair Prescription Drug Competition Act, S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 and General Importation issues, S. 1232 Preserve Access to Affordable Generics Act; Senator McCain Importation Amendments to FDA Approps Homeland Security Department and Justice Department Appropriations bills.

LobbyistCovered position, as disclosed
ANDREA WILKINSON Sen. Breaux, House MMF Comm., Cong. McCrery

Contacted: HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA)

Bills named: S. 369 (111th), S. 525 (111th), S. 1232 (111th), H.R. 573 (111th), S. 501 (111th)

Manufacturing MAN

HR 759 Food and Drug Administration Globalization Act of 2009, S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 and General Importation issues, H.R. 2749 Food Safety Safety Enhancement Act, S. 882 The Drug and Device Accountability Act of 2009

LobbyistCovered position, as disclosed
LAURA ELIZABETH CLINE —
DEBORAH LYNN WALTER MedPAC
ANDREA WILKINSON Sen. Breaux, House MMF Comm., Cong. McCrery

Contacted: Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA)

Bills named: H.R. 2749 (111th), S. 525 (111th), S. 882 (111th), H.R. 759 (111th)

Copyright/Patent/Trademark CPT

S. 515, S. 610 and HR 1260 Patent Reform Acts; H.R. 427 Promoting Innovation and Access to Live-saving Medicine Act, HR 1548 Pathway for Biosimilars Act, S. 726 Licensing of biosimilar/biogeneric products, H.R. 1706 Protecting Consumer Access to Generic Drugs, general patent reform and settlement issues, general follow-on-biologic issues

LobbyistCovered position, as disclosed
ANDREA WILKINSON Sen. Breaux, House MMF Comm, Cong. McCrery

Contacted: Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 726 (111th), S. 515 (111th), S. 610 (111th), H.R. 427 (111th), H.R. 1548 (111th), H.R. 1706 (111th), H.R. 1260 (111th)

Health Issues HCR

S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, H.R. 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance health reformoptions H.R. 1995 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2009, FTC Report "Emerging Health Care Issues: Follow-on Bilogic Drug Competition," mental health parity, value based insurance design, quality of care, adhereance.

LobbyistCovered position, as disclosed
LAURA ELIZABETH CLINE —
NIMISH SHAH New —
DEBORAH LYNN WALTER MedPAC
ANDREA WILKINSON Sen. Breaux, House MMF Comm., Cong. McCrery

Contacted: SENATE; Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1548 (111th), S. 301 (111th), H.R. 427 (111th), S. 623 (111th), H.R. 1995 (111th), S. 537 (111th), H.R. 3200 (111th), S. 726 (111th)

Medicare/Medicaid MMM

HR. 444 340B Program Improvement and Integrity Act of 2009, HR 684/S 330 The Medicare Prescription Drug Savings and Choice Act of 2009, HR 904 Medicaid Prescription Drug Rebate Equalization Act of 2009, Part D general issues, Protected Classes, Comparative Effectiveness, general Medicare/Medicaid expansions and reform, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance Committee Roundtable health reform options

LobbyistCovered position, as disclosed
LAURA ELIZABETH CLINE —
NIMISH SHAH New —
DEBORAH LYNN WALTER MedPAC
ANDREA WILKINSON Sen. Breaux, House MMF Comm., Cong. McCrery

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ)

Bills named: H.R. 3200 (111th), H.R. 904 (111th), H.R. 444 (111th), H.R. 684 (111th)

Budget/Appropriations BUD

FY 2010 U.S. Treasury Green Book on Administration; H.Con.Res 85/S.Con.Res. 13 Concurrent Resolution on the Budget for FY2010; HR 2997 FY 2010 Agriculture Appropriations; FY 2010 Homeland Security Department; FY 2010 Commerce State Justice Appropriations

LobbyistCovered position, as disclosed
NIMISH SHAH New —
ANDREA WILKINSON Sen. Breaux, House MMF Comm., Cong. McCrery

Contacted: Agency for Healthcare Research & Quality (AHRQ); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.Con.Res. 85 (111th), H.R. 2997 (111th), S.Con.Res. 13 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.